CLIN
Michael Narkewicz, MD
Pediatrics
University of Colorado SOM and Children's Hospital Colorado
Zachary Sellers, MD, PhD
Pediatrics
Stanford University
Liver abnormalities associated with cystic fibrosis are a common vexing problem, one that has only become more complex with CFTR modulator therapies. This workshop will provide a mix of invited presentations focused on the revised CF Liver Disease Guidelines that are currently in development and abstract presentations focused on hepatobiliary complications in CF.
Educational Objectives:
1) To describe the recommendations for liver involvement screening in cystic fibrosis
2) To summarize the recommendations for monitoring in people with CF who have liver involvement
3) To discuss recent advances in liver research in CF
Speaker: Senthilkumar Sankararaman, MD – UH Rainbow Babies and Children's Hospital/Case Western Reserve University
Speaker: David N. Assis, MD – Yale School of Medicine
Speaker: Daniel H. Tewkesbury, MBBS, BSc, MRCP(UK) – Manchester University NHS Foundation Trust
Speaker: Meghana Sathe, MD – University of Texas Southwestern and Children's Medical Center Dallas
Speaker: Jaclyn R. Stonebraker, PhD – University of North Carolina at Chapel Hill